Abstract
Rubidomycin can be used alone or in association with other drugs. The dose varies according to the disease and according to the stage of the disease, the details being given elsewhere for each of the main therapeutic indications. We shall confine ourselves here to some general remarks.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Rights and permissions
Copyright information
© 1969 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Bernard, J., Paul, R., Boiron, M., Jacquillat, C., Maral, R. (1969). Posology. In: Bernard, J., Paul, R., Boiron, M., Jacquillat, C., Maral, R. (eds) Rubidomycin. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-88125-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-88125-1_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-88127-5
Online ISBN: 978-3-642-88125-1
eBook Packages: Springer Book Archive